
Atossa Therapeutics Inc is a clinical-stage pharmaceutical company operating in us. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other brea... Atossa Therapeutics Inc is a clinical-stage pharmaceutical company operating in us. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0809 | -8.89010989011 | 0.91 | 0.934 | 0.8104 | 677196 | 0.86503743 | CS |
4 | -0.1509 | -15.3979591837 | 0.98 | 1 | 0.7302 | 665430 | 0.8530192 | CS |
12 | 0.0591 | 7.67532467532 | 0.77 | 1.07 | 0.5526 | 695522 | 0.79116535 | CS |
26 | -0.2419 | -22.5863678805 | 1.071 | 1.08 | 0.5526 | 696941 | 0.8304217 | CS |
52 | -0.3309 | -28.525862069 | 1.16 | 1.66 | 0.5526 | 763751 | 1.08580683 | CS |
156 | -0.1809 | -17.9108910891 | 1.01 | 2.31 | 0.5 | 765623 | 1.13311225 | CS |
260 | -2.2109 | -72.7269736842 | 3.04 | 9.8 | 0.5 | 3619929 | 3.10343536 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.